ES2358146B1 - Uso de células mesenquimales nestina positivas para el mantenimiento de la hematopoyesis. - Google Patents
Uso de células mesenquimales nestina positivas para el mantenimiento de la hematopoyesis. Download PDFInfo
- Publication number
- ES2358146B1 ES2358146B1 ES200930890A ES200930890A ES2358146B1 ES 2358146 B1 ES2358146 B1 ES 2358146B1 ES 200930890 A ES200930890 A ES 200930890A ES 200930890 A ES200930890 A ES 200930890A ES 2358146 B1 ES2358146 B1 ES 2358146B1
- Authority
- ES
- Spain
- Prior art keywords
- maintenance
- hematopoiesis
- stem cell
- cells
- positive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0664—Dental pulp stem cells, Dental follicle stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0666—Mesenchymal stem cells from hair follicles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0668—Mesenchymal stem cells from other natural sources
-
- C12N5/0675—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Uso de células mesenquimales nestina positivas para el mantenimiento de la hematopoyesis.#La presente invención se refiere al uso de al menos una célula madre multipotencial aislada para el mantenimiento de la hematopoyesis in vitro donde preferiblemente dicha célula madre multipotencial es una célula madre mesenquimal o más preferiblemente dicha célula madre mesenquimal es una célula mesenquimal capaz de expresar la proteína nestina. Si la célula madre multipotencial procede de un embrión humano, ésta se obtiene sin destruir dicho embrión. La presente invención también se refiere al uso de cualquiera de las células madre descritas anteriormente para la fabricación de un medicamento para el mantenimiento de la hematopoyesis de un mamífero, o para la prevención y/o el tratamiento de al menos una enfermedad asociada con una disfunción del mantenimiento de la hematopoyesis de un mamífero. Asimismo, la presente invención también se refiere a un método para el mantenimiento de la hematopoyesis in vitro o a un método para evaluar la capacidad hematopoyética de un mamífero.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200930890A ES2358146B1 (es) | 2009-10-22 | 2009-10-22 | Uso de células mesenquimales nestina positivas para el mantenimiento de la hematopoyesis. |
EP10824506.9A EP2492341A4 (en) | 2009-10-22 | 2010-10-22 | PLURIPOTENT CELLS OF POSITIVE NESTINE |
PCT/ES2010/070682 WO2011048253A1 (es) | 2009-10-22 | 2010-10-22 | Células multipotenciales nestina positivas |
US13/503,137 US20130022582A1 (en) | 2009-10-22 | 2010-10-22 | Multipotent nestin-positive cells |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200930890A ES2358146B1 (es) | 2009-10-22 | 2009-10-22 | Uso de células mesenquimales nestina positivas para el mantenimiento de la hematopoyesis. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2358146A1 ES2358146A1 (es) | 2011-05-06 |
ES2358146B1 true ES2358146B1 (es) | 2012-03-23 |
Family
ID=43880330
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES200930890A Expired - Fee Related ES2358146B1 (es) | 2009-10-22 | 2009-10-22 | Uso de células mesenquimales nestina positivas para el mantenimiento de la hematopoyesis. |
Country Status (4)
Country | Link |
---|---|
US (1) | US20130022582A1 (es) |
EP (1) | EP2492341A4 (es) |
ES (1) | ES2358146B1 (es) |
WO (1) | WO2011048253A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104508124B (zh) | 2011-07-06 | 2017-11-17 | 细胞治疗有限公司 | 中胚层谱系祖细胞 |
BR112017025586A2 (pt) * | 2015-05-28 | 2018-08-07 | Celularity Inc | células tronco derivadas da placenta para restaurar o mecanismo regenerativo, corrigir defeitos proteômicos e prolongar a vida útil |
WO2017027512A1 (en) * | 2015-08-13 | 2017-02-16 | Teva Pharmaceutical Industries Ltd. | Use of laquinimod to treat traumatic brain injury |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020123143A1 (en) * | 1997-08-22 | 2002-09-05 | Jean Toma | Multipotent stem cells from peripheral tissues and uses thereof |
WO2008148105A1 (en) * | 2007-05-25 | 2008-12-04 | Medistem Laboratories, Inc. | Endometrial stem cells and methods of making and using same |
-
2009
- 2009-10-22 ES ES200930890A patent/ES2358146B1/es not_active Expired - Fee Related
-
2010
- 2010-10-22 US US13/503,137 patent/US20130022582A1/en not_active Abandoned
- 2010-10-22 EP EP10824506.9A patent/EP2492341A4/en not_active Withdrawn
- 2010-10-22 WO PCT/ES2010/070682 patent/WO2011048253A1/es active Application Filing
Also Published As
Publication number | Publication date |
---|---|
EP2492341A1 (en) | 2012-08-29 |
EP2492341A4 (en) | 2013-09-11 |
US20130022582A1 (en) | 2013-01-24 |
ES2358146A1 (es) | 2011-05-06 |
WO2011048253A1 (es) | 2011-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR080030A1 (es) | Tratamiento de tipos de cancer oseo mediante el uso de celulas madre placentarias | |
AR106768A1 (es) | Composiciones que comprenden cepas bacterianas | |
CL2013002573A1 (es) | Composición que comprende un extracto o preparación de heces humanas; metodo para reemplazar o complementar o modificar la microbiota de colon de un sujeto; uso de dicha composicion para tratar enfermedad o afección patológica o iatrogénica del colon. | |
SV2011004019A (es) | 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso | |
BRPI0814894A2 (pt) | Diferenciação de células-tronco embrionárias de ser humano. | |
EA201391154A2 (ru) | Способы и композиции для нацеливания на адипоциты у млекопитающих | |
AR081166A1 (es) | Angiogenesis por el uso de celulas madre placentarias | |
GT201200313A (es) | 5-fluoro-1h-pirazolopiridinas sustituidas y su uso | |
ECSP13012379A (es) | Pirimidinas y triazinas condensadas y su uso | |
GT201400033A (es) | Pirimidinas anilladas sustituidas y uso de las mismas | |
CR20110470A (es) | Proteínas de union a il-17 | |
WO2011139357A8 (en) | Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases | |
CL2012001950A1 (es) | Uso de una cepa bacteriana probiotico en la fabricacion de un medicamento o composicion nutricional en humanos o animales para alterar los patrones del sueño | |
BR112012003847A2 (pt) | imageamento e avaliação de embriões, oócitos e células tronco | |
WO2009017655A3 (en) | Methods and compositions for stimulating the proliferation or differentiation of stem cells with substance p or an analog thereof | |
BR112012021329A2 (pt) | anticorpo monoclonal anti-tnf-<244> completamente humano, método de preparação e uso do mesmo. | |
CU20120007A7 (es) | Método para la inducción de diferenciación de células madre mesenquimales | |
CL2013002934A1 (es) | Polimeros conjugados analogos de prostaglandinas; metodo de preparacion; implante y uso en el tratamiento del glaucoma. | |
WO2013025446A3 (en) | Anti-fzd10 monoclonal antibodies and methods for their use | |
IL261622A (en) | Use of dental pulp stem cells expressing mesenchymal and neuronal markers and the compounds containing them in the treatment of neurological diseases | |
MX2014001393A (es) | 3-(bifenil-3-il)-4-hidroxi-8-metoxi-1-azaespiro[4.5]dec-3-en-2-on as sustituidas. | |
WO2014008181A8 (en) | Decellularized muscle matrix | |
AR084707A1 (es) | Una composicion farmaceutica de combinacion para tratar enfermedades o condiciones asociados al sistema cardiovascular | |
ES2358146B1 (es) | Uso de células mesenquimales nestina positivas para el mantenimiento de la hematopoyesis. | |
CR20110534A (es) | Antagonistas CCR3 DE ARYLSULFONAMIDA 2,5 DISUSTITUIDAS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 2358146 Country of ref document: ES Kind code of ref document: B1 Effective date: 20120323 |
|
FD2A | Announcement of lapse in spain |
Effective date: 20180924 |